COMPOSITIONS OF ADAGRASIB AND mTOR INHIBITORS AND METHODS OF TREATMENT THEREWITH
US-2026097038-A1 · Apr 9, 2026 · US
This page is not indexed by search engines while we improve data quality.
Olson Peter patents
Olson Peter is listed as an inventor on 33 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Olson Peter |
| Total patents | 33 |
| First publication | Sep 1, 2015 |
| Latest publication | Apr 9, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Compositions of adagrasib and mTOR inhibitors and methods of treatment therewith
US-12527795-B2 · Jan 20, 2026 · US
Combination of palbociclib and adagrasib for lung cancer
US-12485122-B2 · Dec 2, 2025 · US
Combination therapies using prmt5 inhibitors and immune checkpoint inhibitors for the treatment of cancer
US-2025312344-A1 · Oct 9, 2025 · US
Combination therapies using prmt5 inhibitors and kras g12d inhibitors for the treatment of cancer
US-2025312343-A1 · Oct 9, 2025 · US
Combination therapies using prmt5 inhibitors and sos1 inhibitors for the treatment of cancer
US-2025312351-A1 · Oct 9, 2025 · US
Combination therapies
US-2025262213-A1 · Aug 21, 2025 · US
Combinations of kras g12d inhibitors with irinotecan and related methods of treatment
US-2025249003-A1 · Aug 7, 2025 · US
Combination therapies
US-12377101-B2 · Aug 5, 2025 · US
Combination therapies
US-2025213579-A1 · Jul 3, 2025 · US
Recent patents
Latest publications not already listed above.
Combination therapies
US-12336995-B2 · Jun 24, 2025 · US
Combination therapies
US-2025108055-A1 · Apr 3, 2025 · US
Combination Therapies Using PRMT5 Inhibitors for the Treatment of Cancer
US-2025073241-A1 · Mar 6, 2025 · US
Combination therapies
US-12208099-B2 · Jan 28, 2025 · US
Combination therapies of kras g12d inhibitors with sos1 inhibitors
US-2025000863-A1 · Jan 2, 2025 · US
Combination Therapies Using PRMT5 Inhibitors for the Treatment of Cancer
US-2024423987-A1 · Dec 26, 2024 · US
Combination therapies of kras g12d inhibitors with shp-2 inhibitors
US-2024423984-A1 · Dec 26, 2024 · US
Combination therapies using PRMT5 inhibitors for the treatment of cancer
US-12171765-B2 · Dec 24, 2024 · US
COMBINATIONS OF KRAS G12D INHIBITORS WITH PI3Ka INHIBITORS AND RELATED METHODS OF TREATMENT
US-2024408098-A1 · Dec 12, 2024 · US
COMBINATION THERAPIES OF KRAS G12D INHIBITORS WITH Pan ErbB FAMILY INHIBITORS
US-2024408099-A1 · Dec 12, 2024 · US
Combination therapies using prmt5 inhibitors for the treatment of cancer
US-2024398795-A1 · Dec 5, 2024 · US
Combination therapies using PRMT5 inhibitors for the treatment of cancer
US-12128048-B2 · Oct 29, 2024 · US
Combination therapies
US-2024156821-A1 · May 16, 2024 · US
Combination therapies
US-11890285-B2 · Feb 6, 2024 · US
Combination Therapies Using PRMT5 Inhibitors for the Treatment of Cancer
US-2022331324-A1 · Oct 20, 2022 · US
Combination Therapies Using PRMT5 Inhibitors for the Treatment of Cancer
US-2022331323-A1 · Oct 20, 2022 · US
Combination therapies
US-2022096482-A1 · Mar 31, 2022 · US
Combination therapies
US-2022079947-A1 · Mar 17, 2022 · US
Combination therapies
US-2022054491-A1 · Feb 24, 2022 · US
Combination therapies
US-2022054492-A1 · Feb 24, 2022 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Mirati Therapeutics Inc | 32 |
| Disney Entpr Inc | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 32 |
| A61K45/06 | 32 |
| A61K31/519 | 29 |
| A61K2300/00 | 20 |
| A61K31/5377 | 14 |